RELMADA THERAPEUTICS, INC. — Director's Dealing 2020

Aug 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2020-08-18

Reporting Person: CASAMENTO CHARLES J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-18	Common Stock	M	26362	$3.24	Acquired	60362	Direct
2020-08-18	Common Stock	F	2189	$39.03	Disposed	58173	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-18	Options to purchase common stock	$3.24	M	26362	Disposed	2027-10-20	Common Stock (26362)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21484	Indirect

Footnotes

F1: Represents shares of common stock held by a family trust. Mr. Casamento disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that Mr. Casamento is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.

F2: Reflects 2,189 shares withheld at the market price of $39.03 per share to fund the cashless exercise of 26,362 options owned by Mr. Casamento, which cashless exercise was approved in advance by the Board of Directors.

F3: The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.